Other than miR-106-5p and miR-17-5p, miRNAs such as miR-375, miR-592, and miR-135a also influence breast cancer proliferation by modulating ESR1, ERBB4 pathway [30], and miR-135a function as prognostic marker in ER-positive breast cancer [31]. Here, ERBB4 is linked to breast carcinoma.